CRP and inflammatory bowel disease: Key evidence: There was very-low quality evidence on the role of testing for C-reactive protein (CRP) in IBS patients from a systematic review of biomarker studies, which included four case-control studies (n=224 IBS patients, n=465 inflammatory bowel disease [IBD] patients and n=134 healthy controls) of CRP (20).